ATC
ALXN

Argent Trust Co’s Alexion Pharmaceuticals ALXN Stock Holding History

Argent Trust Co’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,583
Closed -$248K – 246
2015
Q3 		$248K Sell
1,583
-58
-4% -$10.6K 0.14% 192
2015
Q2 		$297K Sell
1,641
-362
-18% -$62.5K 0.15% 184
2015
Q1 		$347K Sell
2,003
-60
-3% -$10.9K 0.18% 169
2014
Q4 		$381K Buy
+2,063
New +$382K 0.23% 132

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Argent Trust Co's ALXN Position: Q4 2015 in Review

Argent Trust Co sold out of Alexion Pharmaceuticals (ALXN) in Q4 2015, closing a stake of 1,583 shares — an estimated $248K sold.

Argent Trust Co first reported a position in ALXN in Q4 2014 and held it in 4 quarters. The position peaked at $381K in Q4 2014. 547 funds tracked by Wall St. Rank hold ALXN as of Q4 2015.

  • Argent Trust Co reported no remaining Alexion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Argent Trust Co sold 1,583 Alexion Pharmaceuticals shares in Q4 2015, an estimated $248K.
  • Argent Trust Co first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Argent Trust Co's Alexion Pharmaceuticals position peaked at $381K in Q4 2014.
  • 547 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2015.

Based on Argent Trust Co's 13F filing for Q4 2015, filed 11 Feb 2016.